Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Evaluation of the in vitro release and pharmacokinetics of parenteral injectable formulations for steroids.

Nippe S, Preuße C, General S.

Eur J Pharm Biopharm. 2013 Feb;83(2):253-65. doi: 10.1016/j.ejpb.2012.09.006. Epub 2012 Oct 29.

PMID:
23116659
2.

Investigation of injectable drospirenone organogels with regard to their rheology and comparison to non-stabilized oil-based drospirenone suspensions.

Nippe S, General S.

Drug Dev Ind Pharm. 2015 Apr;41(4):681-91. doi: 10.3109/03639045.2014.895375. Epub 2014 Mar 12.

PMID:
24621345
3.

Parenteral oil-based drospirenone microcrystal suspensions-evaluation of physicochemical stability and influence of stabilising agents.

Nippe S, General S.

Int J Pharm. 2011 Sep 15;416(1):181-8. doi: 10.1016/j.ijpharm.2011.06.036. Epub 2011 Jun 25.

PMID:
21729745
4.

Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release.

Nippe S, General S.

Eur J Pharm Sci. 2012 Nov 20;47(4):790-800. doi: 10.1016/j.ejps.2012.08.009. Epub 2012 Aug 23.

PMID:
22940138
5.

Novel ethinyl estradiol-beta-cyclodextrin clathrate formulation does not influence the relative bioavailability of ethinyl estradiol or coadministered drospirenone.

Blode H, Schürmann R, Benda N.

Contraception. 2008 Mar;77(3):171-6. doi: 10.1016/j.contraception.2007.10.009. Epub 2008 Jan 22.

PMID:
18279686
6.

Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women.

Blode H, Kowal K, Roth K, Reif S.

Eur J Contracept Reprod Health Care. 2012 Aug;17(4):284-97. doi: 10.3109/13625187.2012.677076. Epub 2012 Jun 10.

7.

Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive.

Keam SJ, Wagstaff AJ.

Treat Endocrinol. 2003;2(1):49-70. Review.

PMID:
15871554
8.

Conception and pharmacodynamic profile of drospirenone.

Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A.

Steroids. 2003 Nov;68(10-13):891-905.

PMID:
14667981
9.

Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Lukacova V, Woltosz WS, Bolger MB.

AAPS J. 2009 Jun;11(2):323-34. doi: 10.1208/s12248-009-9107-2. Epub 2009 May 9.

10.
11.

Comparison of suspension composition on the pharmacokinetics of nimesulide in rats.

Carrasco-Portugal Mdel C, Flores-Murrieta FJ.

Proc West Pharmacol Soc. 2008;51:58-9.

PMID:
19544678
12.

[Preparation and pharmacokinetic evaluation of long-acting injectable oily suspensions for ophiopogonis radix polysaccharide MDG-1].

Shi XL, Yao CX, Lin X, Shen L, Feng Y.

Zhongguo Zhong Yao Za Zhi. 2014 Jul;39(13):2489-94. Chinese.

PMID:
25276969
13.

A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.

Gao Y, Carr RA, Spence JK, Wang WW, Turner TM, Lipari JM, Miller JM.

Mol Pharm. 2010 Oct 4;7(5):1516-26. doi: 10.1021/mp100157s. Epub 2010 Aug 17.

PMID:
20715778
14.

Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.

Rajpoot P, Bali V, Pathak K.

Int J Pharm. 2012 Apr 15;426(1-2):219-30. doi: 10.1016/j.ijpharm.2012.01.027. Epub 2012 Jan 24.

PMID:
22301424
15.
16.

Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).

Khani S, Keyhanfar F.

AAPS PharmSciTech. 2014 Feb;15(1):96-102. doi: 10.1208/s12249-013-0039-x. Epub 2013 Oct 23.

17.

Assessment of drug release from oil depot formulations using an in vitro model -- potential applicability in accelerated release testing.

Larsen SW, Jessen MN, Ostergaard J, Larsen C.

Drug Dev Ind Pharm. 2008 Mar;34(3):297-304. doi: 10.1080/03639040701655994 .

PMID:
18363145
18.

Drospirenone, a progestogen with antimineralocorticoid properties: a short review.

Oelkers W.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):255-61. Review.

PMID:
15134826
19.
20.

Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.

Allahham A, Stewart P, Marriott J, Mainwaring DE.

Int J Pharm. 2004 Feb 11;270(1-2):139-48.

PMID:
14726130

Supplemental Content

Support Center